Atul Pande - 02 Aug 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Aug 2021
Net transactions value
-$245,425
Form type
4
Filing time
02 Aug 2021, 16:49:38 UTC
Previous filing
01 Jul 2021
Next filing
16 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $40,000 +2,500 $16.00* 2,500 02 Aug 2021 Direct
transaction KRTX Common Stock Sale $285,425 -2,500 -100% $114.17 0 02 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2,500 -14% $0.000000 15,000 02 Aug 2021 Common Stock 2,500 $16.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.